Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Induction of CXCR3- and CCR5-associated chemokines during acute hepatitis C virus infection.

Zeremski M, Hooker G, Shu MA, Winkelstein E, Brown Q, Des Jarlais DC, Tobler LH, Rehermann B, Busch MP, Edlin BR, Talal AH.

J Hepatol. 2011 Sep;55(3):545-553. doi: 10.1016/j.jhep.2010.12.033. Epub 2011 Jan 21.

2.

The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection.

Larrubia JR, Calvino M, Benito S, Sanz-de-Villalobos E, Perna C, Pérez-Hornedo J, González-Mateos F, García-Garzón S, Bienvenido A, Parra T.

J Hepatol. 2007 Nov;47(5):632-41. Epub 2007 May 24.

PMID:
17560677
3.

[THE ROLE OF CYTOKINES AND CHEMOKINES IN LABORATORY DIAGNOSTIC OF CHRONIC VIRAL HEPATITIS C].

Semenov AV, Arsentieva NA, Lubimova NE, Tulienev SV, Basina VV, Esaulenko EV, Totolyan AA.

Klin Lab Diagn. 2015 Aug;60(8):45-51. Russian.

PMID:
26596048
4.

Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection.

Zeremski M, Dimova R, Brown Q, Jacobson IM, Markatou M, Talal AH.

J Infect Dis. 2009 Dec 1;200(11):1774-80. doi: 10.1086/646614.

PMID:
19848607
5.

A correlation study between gene polymorphism of Th cell expressed chemokine receptor CXCR3 and its ligand levels with HCV infection prognosis.

Lu Y, Lin LY, Tan JG, Deng HP, Li XH, Zhang Z, Li Y, Zhou Z, Xu X, Xie X, Mei SJ.

Eur Rev Med Pharmacol Sci. 2017 Mar;21(6):1290-1295.

6.

Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C.

Butera D, Marukian S, Iwamaye AE, Hembrador E, Chambers TJ, Di Bisceglie AM, Charles ED, Talal AH, Jacobson IM, Rice CM, Dustin LB.

Blood. 2005 Aug 15;106(4):1175-82. Epub 2005 Apr 28.

7.

CXCR3 and CCR5 chemokines in induced sputum from patients with COPD.

Costa C, Rufino R, Traves SL, Lapa E Silva JR, Barnes PJ, Donnelly LE.

Chest. 2008 Jan;133(1):26-33. Epub 2007 Oct 9.

PMID:
17925429
8.

Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.

Tacke F, Zimmermann HW, Berres ML, Trautwein C, Wasmuth HE.

Liver Int. 2011 Jul;31(6):840-9. doi: 10.1111/j.1478-3231.2011.02504.x. Epub 2011 Mar 10.

PMID:
21645215
9.

Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro.

Helbig KJ, Ruszkiewicz A, Lanford RE, Berzsenyi MD, Harley HA, McColl SR, Beard MR.

J Virol. 2009 Jan;83(2):836-46. doi: 10.1128/JVI.01388-08. Epub 2008 Nov 5.

10.

The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.

Zeremski M, Petrovic LM, Talal AH.

J Viral Hepat. 2007 Oct;14(10):675-87. Review.

PMID:
17875002
11.

Delayed induction, not impaired recruitment, of specific CD8⁺ T cells causes the late onset of acute hepatitis C.

Shin EC, Park SH, Demino M, Nascimbeni M, Mihalik K, Major M, Veerapu NS, Heller T, Feinstone SM, Rice CM, Rehermann B.

Gastroenterology. 2011 Aug;141(2):686-95, 695.e1. doi: 10.1053/j.gastro.2011.05.006. Epub 2011 May 18.

12.

Chemokine and chemokine receptor dynamics during genital chlamydial infection.

Belay T, Eko FO, Ananaba GA, Bowers S, Moore T, Lyn D, Igietseme JU.

Infect Immun. 2002 Feb;70(2):844-50.

13.

A rapid chemokine response of macrophage inflammatory protein (MIP)-1α, MIP-1β and the regulated on activation, normal T expressed and secreted chemokine is associated with a sustained virological response in the treatment of chronic hepatitis C.

Florholmen J, Kristiansen MG, Steigen SE, Sørbye SW, Paulssen EJ, Kvamme JM, Konopski Z, Gutteberg T, Goll R.

Clin Microbiol Infect. 2011 Feb;17(2):204-9. doi: 10.1111/j.1469-0691.2010.03206.x.

14.

Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice.

Wareing MD, Lyon AB, Lu B, Gerard C, Sarawar SR.

J Leukoc Biol. 2004 Oct;76(4):886-95. Epub 2004 Jul 7.

PMID:
15240757
15.

Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C.

Zeremski M, Petrovic LM, Chiriboga L, Brown QB, Yee HT, Kinkhabwala M, Jacobson IM, Dimova R, Markatou M, Talal AH.

Hepatology. 2008 Nov;48(5):1440-50. doi: 10.1002/hep.22500.

16.
18.

Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection.

Hajarizadeh B, Lamoury FM, Feld JJ, Amin J, Keoshkerian E, Matthews GV, Hellard M, Dore GJ, Lloyd AR, Grebely J, Applegate TL; ATAHC Study Group.

Virol J. 2016 Feb 24;13:32. doi: 10.1186/s12985-016-0482-x.

19.

Expression of resistin, CXCR3, IP-10, CCR5 and MIP-1α in obese patients with different severity of asthma.

Rojas-Dotor S, Segura-Méndez NH, Miyagui-Namikawa K, Mondragón-González R.

Biol Res. 2013;46(1):13-20. doi: 10.4067/S0716-97602013000100002.

20.

Expression of CXCR3 and its ligands CXCL9, -10 and -11 in paediatric opsoclonus-myoclonus syndrome.

Pranzatelli MR, Tate ED, McGee NR, Travelstead AL, Verhulst SJ, Ransohoff RM.

Clin Exp Immunol. 2013 Jun;172(3):427-36. doi: 10.1111/cei.12065.

Supplemental Content

Support Center